Principal Investigator: Peter Gottlieb, COMIRB #: 06-0627
- The BHT Research Study is looking for people diagnosed with type 1 diabetes who may still producing some of their own insulin.
- This research study will test the medication BHT-3021 to see if it is safe.
- Secondarily, the research study will see if BHT-3021 can help maintain the body’s ability to produce some insulin.
Why should you consider this study?
- You will be part of a research study to see if we can stop your slow down your body’s attack of on the cells that produce insulin.
- If the study drug is successful, you may have an easier time managing your diabetes.
- The information from this study may help other people with diabetes.
Who can sign up for this study?
- People who have been diagnosed with Type 1 Diabetes.
- 18 - 45 years old.
- 40 years old or less at the time of diagnosis with type 1 diabetes.
- People who may be producing some of their own insulin.
What will happen in this study?
- You will be assessed for general health and diabetes care.
- If you qualify, you will receive 12 weekly treatments with study medication or fake medication.
- If you receive the fake medication, you can receive the study medication after one year.
- You will be monitored for 2-5 years to look at your overall diabetes health.
Who should I call with questions or to schedule an appointment?
Sandy Barry: 303-724-7501 or Sandra.Barry@ucdenver.edu
Lisa Meyers: 303.724.6893 or Lisa.Meyers@ucdenver.edu